Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 192 publications
Assessing Differences Between Epigenetic versus Chronologic Age for Cardiovascular Risk Assessments in the United States.
Journal: Circulation. Population health and outcomes
Published: August 31, 2026
Statins In Dialysis-Dependent End-Stage Renal Disease: Reconciling Discordant Evidence Through GRADE-Informed Appraisal and Evidence-to-Decision Framework.
Journal: Journal of cardiovascular pharmacology
Published: August 28, 2026
Modifiable Risk Factors and Attributable Ischemic Heart Disease Mortality in US States, 1990-2023: A Systematic Analysis for the Global Burden of Disease Study 2023.
Journal: JAMA cardiology
Published: July 15, 2026
Association of increased coronary physiology and intracoronary imaging use with downstream healthcare costs.
Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: June 16, 2026
Diagnosis and Management of Loeys-Dietz Syndrome: Evidence Gaps and Future Directions.
Journal: Current cardiology reports
Published: June 02, 2026
Lipoprotein(a) and Risk of Treated Ventricular Arrhythmias in Heart Failure.
Journal: JAMA network open
Published: May 26, 2026
GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Hypertrophic Cardiomyopathy with Type 2 Diabetes: A Propensity Score-Matched Real-World Analysis.
Journal: The American journal of cardiology
Published: May 06, 2026
Nutritional Interventions in Cardiac Rehabilitation: Current Evidence, Evidence Gaps, and Future Directions-A Scoping Review.
Journal: European journal of preventive cardiology
Published: April 25, 2026
Estimated VESALIUS-Like Eligibility and Projected Cardiovascular Benefit in US Adults.
Journal: European heart journal. Quality of care & clinical outcomes
Published: April 13, 2026
Percutaneous micro-axial flow pump use during non-emergent high-risk PCI: The authors reply.
Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: April 13, 2026
GLP-1 receptor agonists associated with better cardiovascular outcomes in obese or diabetic patients with elevated Lp(a) levels: A Multicenter retrospective study.
Journal: International journal of cardiology
Published: April 10, 2026
Last Updated: 09/26/2026